|
|
|
| Efficacy and safety of Dexmedetomidine combined with Butorphanol for postoperative analgesia in patients with microvascular decompression#br# |
| CAI Botao TANG Ting LIAO Sha ZHANG Baiyin TANG Jiwei |
| Department of Anesthesiolgy and Surgry, Hunan Brain Hospital, Hunan Province, Changsha 410007, China |
|
|
|
Abstract Objective To investigate the efficacy and safety of Dexmedetomidine combined with Butorphanol for postoperative analgesia in patients with microvascular decompression. Methods A total of 40 patients scheduled for microvascular decompression in Hunan Brain Hospital from January 2019 to December 2020 were selected, they were divided into Butorphanol group (group C) and Butorphanol combined with Dexmedetomidine group (Group D) according to the random number table method, with 20 cases in each group. Patient controlled intravenous analgesia was performed after operation. Group C received Butorphanol 10 mg + Tropisetron 5 mg, and group D received Butorphanol 10 mg + Dexmedetomidine 200 μg + Tropisetron 5 mg, diluted to 100 ml with normal saline. The mean arterial pressure (MAP) and heart rate (HR) of both groups were recorded before operation (T0) and after operation at 4 h (T1), 12 h (T2), 24 h (T3), and 48 h (T4); visual analogue scale (VAS) score and Ramsay sedation score were recorded after T1-T4 in both groups; adverse reactions and sleep quality scores were recorded. Results In group C, MAP values at T1-T2 were higher than those at T0, and MAP values at T3-T4 were lower than those at T1-T2, and the differences were statistically significant (P < 0.05). MAP values of group D at T2-T4 were lower than those at T1, and the differences were statistically significant (P < 0.05). MAP values of group D at T1-T4 were lower than those of group C, and the differences were statistically significant (P < 0.05). In group C, HR values at T2-T4 were lower than those at T0 and T1, and the differences were statistically significant (P < 0.05). In group D, HR values at T2-T4 were lower than those at T0 and T1, while HR value at T4 was higher than that at T3, and the differences were statistically significant (P < 0.05). HR values of group D at T1-T4 were lower than those of group C, and the differences were statistically significant (P < 0.05). There were statistically significant differences in the resting and active VAS scores in group C at each time points (P < 0.05). In group D, the resting VAS scores at T2-T3 were lower than those at T1, and the resting VAS score at T4 was lower than that at T1-T3, and the differences were statistically significant (P < 0.05); there were statistical significances in active VAS score in group D at each time points (P < 0.05). The resting and active VAS scores of group D at T1-T4 were lower than those of group C, and the differences were statistically significant (P < 0.05). Ramsay sedation scores in group D at T1-T4 were higher than those in group C, and the differences were statistically significant (P < 0.05). The total incidence of adverse reactions in group D was lower than that in group C, and the difference was statistically significant (P < 0.05). There was no significant difference in sleep quality before and after operation in group C (P > 0.05); the sleep quality of group D after operation was better than that before operation, and the difference was statistically significant (P < 0.05). Sleep quality of group D after operation was better than that of group C, and the difference was statistically significant (P < 0.05). Conclusion Dexmedetomidine combined with Butorphanol for postoperative analgesia after microvascular decompression is safe and effective. It can provide good sedative and analgesic effect, improve sleep quality and reduce adverse reactions.
|
|
|
|
|
|
[1] 杨学平，何茹.三叉神经痛患者抑郁焦虑的现状研究[J].中国现代医生，2016，54（32）：162-164，168.
[2] 李付勇，马逸，邹建军，等.三叉神经痛微球囊压迫治疗后疼痛未缓解临床思考[J].中国疼痛医学杂志，2010，16（6）：362-363.
[3] 赵道霞，张保应，张阿锋，等.舒芬太尼预防性镇痛对剖宫产术产妇VAS评分及应激指标影响[J].中国计划生育学杂志，2020，28（10）：1688-1690，1694.
[4] 宋芬，刘玥，殷霞丽，等.右美托咪定辅助麻醉对老年腹部重症病患术后谵妄以及Ramsay镇静评分的影响[J].现代生物医学进展，2020，20（12）：2275-2279.
[5] 马盼盼，张晓栋，沈阳，等.咪达唑仑复合舒芬太尼对三叉神经痛患者微血管减压术后镇静镇痛的效果[J].中国疼痛医学杂志，2016，22（11）：857-860.
[6] Bennetto L，Patel NK，Fuller G. Trigeminal neuralgia and its management [J]. BMJ，2007，334（7586）：201-205.
[7] 曹冰莹，王婷，龚丽，等.三叉神经痛患者应对方式与焦虑抑郁的相关性[J].中国实用神经疾病杂志，2015，18（19）：75-76.
[8] 孙雯，彭国平，徐铭玮，等.原发性三叉神经痛患者伴发焦虑抑郁及睡眠障碍的临床研究[J].浙江医学，2016，38（4）：271-274.
[9] 杨鸿雁，李晨军.三叉神经痛患者生活质量研究[J].西南国防医药，2012，22（5）：573-575.
[10] 徐武，梁维邦，陆天宇.微血管减压术治疗颅神经疾病1982例临床分析[J].立体定向和功能性神经外科杂志，2016，29（1）：9-12.
[11] 薛纯纯，谢磊，沙中玮，等.神经病理性疼痛与睡眠障碍[J].中国疼痛医学杂志，2020，26（7）：522-525.
[12] 赵文菊.用阿片类镇痛药对老年恶性肿瘤伴癌痛患者进行镇痛治疗的效果及安全性分析[J].当代医药论丛，2019，17（1）：26-27.
[13] 韩涛.多模式镇痛用于腹腔镜子宫肌瘤切除术的镇痛效果及对应激反应的影响[J].中国妇幼保健，2021，36（11）：2496-2498.
[14] 王海峰，屈传伟，王琛，等.加速术后康复理念下多模式镇痛应用在腹腔镜胰十二指肠切除术患者中的作用[J].麻醉安全与质控，2021，5（4）：207-210.
[15] 史记，张娜娜，赵帅，等.盐酸右美托咪定对颅内动脉瘤介入手术患者血流动力学及术后并发症的影响[J].中国医药导报，2020，17（7）：115-119.
[16] 罗显刚，肖倩兰.右美托咪定对全身麻醉老年患者术后的临床效果及对早期认知功能的影响[J].中外医学研究，2021，19（8）：120-122.
[17] 吴瑶，李亚玲，李建长.右美托咪定对全身麻醉下腹腔镜子宫切除术中血流动力学及应激反应的影响[J].临床和实验医学杂志，2020，19（10）：1108-1113.
[18] 张素芹，徐文平，赵艳萍，等.静脉右美托咪定对剖宫产术中产妇镇静的适宜剂量[J].中国现代医生，2021，59（13）：126-130.
[19] 谢荣裕，陈建军，张娟，等.右美托咪定、丙泊酚联合酒石酸布托啡诺对重症患者镇静镇痛效果及血流动力学的影响[J].中国急救复苏与灾害医学杂志，2020，15（8）：973-976.
[20] 赵林，赵婷.右美托咪定超前镇痛对老年下肢骨折手术患者术后疼痛及血液流变学状态的影响[J].检验医学与临床，2021，18（15）：2282-2283，2299.
[21] 乔迁，康芳，黄祥，等.右美托咪定复合罗哌卡因胸椎旁神经阻滞对胸腹腔镜联合食管癌根治术术后恢复质量的影响[J].临床麻醉学杂志，2021，37（5）：453-457.
[22] 王开，段光友，赵鹏，等.右美托咪定术中持续泵注对脊柱手术患者术后睡眠质量的改善作用[J].第三军医大学学报，2020，42（10）：1002-1007.
[23] 杜凤英，何高鹰，陈晓燕，等.右美托咪定对睡眠障碍老年脊柱手术患者术后睡眠质量的影响研究[J].世界睡眠医学杂志，2019，6（1）：55-57.
[24] 郑玉玲，罗文芬.布托啡诺、地佐辛联合芬太尼用于腹腔镜术后PCIA效果观察[J].上海医药，2021，42（7）：37-40.
[25] 佟鑫，满羽飞，杨雨霖，等.酒石酸布托啡诺在临床麻醉中的应用进展[J].国际麻醉学与复苏杂志，2020，41（12）：1177-1181.
[26] 宋比佳，朱俊超.布托啡诺对中老年焦虑患者术中镇静情况及术后睡眠质量的影响[J].中华实用诊断与治疗杂志，2019，33（6）：601-603.
[27] 吴新民，薛张纲，马虹，等.右美托咪定临床应用专家共识（2018）[J].临床麻醉学杂志，2018，34（8）：820-823.
[28] 夏伟峰，蔡建龙，刘军.右美托咪定联合布托啡诺超前镇痛对直肠癌手术患者的麻醉效果[J].中国乡村医药，2021，28（10）：20-21.
[29] 陈势，陶真，林忠宇.右美托咪定复合布托啡诺在ICU患者持续镇静中的应用[J].浙江临床医学，2020，22（7）：1036-1038. |
|
|
|
